MBNL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.193000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.232400E-01
Normal-vs-Stage2
3.303600E-01
Normal-vs-Stage3
2.461600E-01
Normal-vs-Stage4
2.556600E-01
Stage1-vs-Stage2
8.440600E-01
Stage1-vs-Stage3
3.520200E-01
Stage1-vs-Stage4
6.770800E-01
Stage2-vs-Stage3
8.700400E-03
Stage2-vs-Stage4
7.647200E-01
Stage3-vs-Stage4
2.460600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.184400E-01
Normal-vs-AfricanAmerican
2.216000E-01
Normal-vs-Asian
2.617600E-01
Caucasian-vs-AfricanAmerican
4.335800E-01
Caucasian-vs-Asian
2.415200E-01
AfricanAmerican-vs-Asian
1.700990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.082800E-01
Normal-vs-Female
3.363400E-01
Male-vs-Female
3.409000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.306800E-01
Normal-vs-Age(41-60Yrs)
3.898400E-01
Normal-vs-Age(61-80Yrs)
2.955000E-01
Normal-vs-Age(81-100Yrs)
2.823600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.685800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.004400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.714200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.155200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.453900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.675400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.807600E-01
Normal-vs-Daily Drinker
2.561200E-01
Normal-vs-Weekly Drinker
2.793600E-01
Normal-vs-Occasional Drinker
2.969000E-01
Normal-vs-Social Drinker
8.927800E-02
Non Drinker-vs-Daily Drinker
5.219800E-01
Non Drinker-vs-Weekly Drinker
9.584400E-01
Non Drinker-vs-Occasional Drinker
7.582600E-01
Non Drinker-vs-Social Drinker
1.731800E-01
Daily Drinker-vs-Weekly Drinker
5.790000E-01
Daily Drinker-vs-Occasional Drinker
3.470400E-01
Daily Drinker-vs-Social Drinker
9.284400E-02
Weekly Drinker-vs-Occasional Drinker
7.423600E-01
Weekly Drinker-vs-Social Drinker
2.269600E-01
Occasional Drinker-vs-Social Drinker
3.239600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.447600E-01
Normal-vs-Grade 2
2.321600E-02
Normal-vs-Grade 3
2.516200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.868440E-01
Grade 1-vs-Grade 3
5.911000E-01
Grade 1-vs-Grade 4
2.447600E-01
Grade 2-vs-Grade 3
1.866620E-01
Grade 2-vs-Grade 4
2.321600E-02
Grade 3-vs-Grade 4
2.516200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.194400E-01
Normal-vs-NonDiabetic
2.926000E-01
Diabetic-vs-NonDiabetic
4.337800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.988800E-01
Normal-vs-NoPancreatitis
3.038000E-01
Pancreatitis-vs-NoPancreatitis
8.567400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.059600E-01
Normal-vs-N1
3.295400E-01
N0-vs-N1
4.305400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.579600E-01
Normal-vs-TP53-NonMutant
3.057600E-01
TP53-Mutant-vs-TP53-NonMutant
2.344200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
